JP2001504689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001504689A5 JP2001504689A5 JP1998519754A JP51975498A JP2001504689A5 JP 2001504689 A5 JP2001504689 A5 JP 2001504689A5 JP 1998519754 A JP1998519754 A JP 1998519754A JP 51975498 A JP51975498 A JP 51975498A JP 2001504689 A5 JP2001504689 A5 JP 2001504689A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2962996P | 1996-10-25 | 1996-10-25 | |
| US60/029,629 | 1996-10-25 | ||
| PCT/US1997/020037 WO1998017810A2 (en) | 1996-10-25 | 1997-10-23 | Multi-functional chimeric hematopoietic receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001504689A JP2001504689A (ja) | 2001-04-10 |
| JP2001504689A5 true JP2001504689A5 (ru) | 2005-05-12 |
Family
ID=21850035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51975498A Abandoned JP2001504689A (ja) | 1996-10-25 | 1997-10-23 | 多機能性キメラ造血レセプターアゴニスト |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0935663A2 (ru) |
| JP (1) | JP2001504689A (ru) |
| KR (1) | KR100497423B1 (ru) |
| AR (1) | AR010041A1 (ru) |
| AU (1) | AU725547B2 (ru) |
| BR (1) | BR9713668A (ru) |
| CA (1) | CA2268742A1 (ru) |
| CZ (1) | CZ295843B6 (ru) |
| IL (1) | IL129565A0 (ru) |
| NO (1) | NO991948L (ru) |
| NZ (1) | NZ335382A (ru) |
| PL (1) | PL333023A1 (ru) |
| RO (1) | RO120919B1 (ru) |
| RU (2) | RU2245887C2 (ru) |
| TW (2) | TW200413407A (ru) |
| WO (1) | WO1998017810A2 (ru) |
| ZA (1) | ZA979607B (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
| US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2001527396A (ja) * | 1997-04-11 | 2001-12-25 | ジー．ディー．サール アンド カンパニー | ｆｌｔ３リガンドキメラタンパク質 |
| BR9905867A (pt) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula |
| WO2002101047A1 (en) * | 2001-06-12 | 2002-12-19 | Smithkline Beecham Corporation | Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities |
| JP4444652B2 (ja) | 2001-07-11 | 2010-03-31 | マキシゲン・ホールディングズ・リミテッド | Ｇ−ｃｓｆ結合体 |
| ATE447611T1 (de) | 2003-08-18 | 2009-11-15 | Univ California | Polypeptid-display-bibliotheken und verfahren zur herstellung und verwendung davon |
| CN101193658B (zh) | 2005-06-01 | 2011-08-31 | 马克西根控股公司 | 聚乙二醇化g-csf多肽及其产生方法 |
| US7550433B2 (en) * | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
| AU2006284651C1 (en) | 2005-08-31 | 2013-09-12 | The Regents Of The University Of California | Cellular libraries of peptide sequences (CLiPS) and methods of using the same |
| WO2007098548A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
| US8293685B2 (en) * | 2007-07-26 | 2012-10-23 | The Regents Of The University Of California | Methods for enhancing bacterial cell display of proteins and peptides |
| US10071109B2 (en) | 2013-11-06 | 2018-09-11 | Molecular Templates, Inc. | Predictive biomarker for hypoxia-activated prodrug therapy |
| WO2020198659A1 (en) * | 2019-03-28 | 2020-10-01 | Orionis Biosciences, Inc. | Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006116A1 (en) * | 1990-09-28 | 1992-04-16 | Ortho Pharmaceutical Corporation | Hybrid growth factors |
| US5376367A (en) * | 1991-11-22 | 1994-12-27 | Immunex Corporation | Fusion proteins comprising MGF and IL-3 |
| US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| US6057133A (en) * | 1992-11-24 | 2000-05-02 | G. D. Searle | Multivariant human IL-3 fusion proteins and their recombinant production |
| US5635599A (en) * | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
-
1997
- 1997-10-23 AU AU51652/98A patent/AU725547B2/en not_active Ceased
- 1997-10-23 CA CA002268742A patent/CA2268742A1/en not_active Abandoned
- 1997-10-23 CZ CZ19991323A patent/CZ295843B6/cs not_active IP Right Cessation
- 1997-10-23 PL PL97333023A patent/PL333023A1/xx unknown
- 1997-10-23 KR KR10-1999-7003635A patent/KR100497423B1/ko not_active IP Right Cessation
- 1997-10-23 BR BR9713668-9A patent/BR9713668A/pt not_active Application Discontinuation
- 1997-10-23 RU RU99111071/13A patent/RU2245887C2/ru not_active IP Right Cessation
- 1997-10-23 EP EP97946495A patent/EP0935663A2/en not_active Withdrawn
- 1997-10-23 IL IL12956597A patent/IL129565A0/xx unknown
- 1997-10-23 RO RO99-00480A patent/RO120919B1/ro unknown
- 1997-10-23 WO PCT/US1997/020037 patent/WO1998017810A2/en not_active Application Discontinuation
- 1997-10-23 JP JP51975498A patent/JP2001504689A/ja not_active Abandoned
- 1997-10-23 NZ NZ335382A patent/NZ335382A/xx unknown
- 1997-10-27 TW TW093111460A patent/TW200413407A/zh unknown
- 1997-10-27 TW TW086116018A patent/TW591035B/zh not_active IP Right Cessation
- 1997-10-27 ZA ZA979607A patent/ZA979607B/xx unknown
- 1997-10-28 AR ARP970104979A patent/AR010041A1/es unknown
-
1999
- 1999-04-23 NO NO991948A patent/NO991948L/no not_active Application Discontinuation
-
2005
- 2005-02-24 RU RU2005105360/13A patent/RU2005105360A/ru not_active Application Discontinuation